Covetrus Revenue and Competitors
Estimated Revenue & Valuation
- Covetrus's estimated annual revenue is currently $4.6B per year.
- Covetrus's estimated revenue per employee is $1,401,040
- Covetrus's current valuation is $2.2B. (January 2022)
Employee Data
- Covetrus has 3269 Employees.
- Covetrus grew their employee count by 3% last year.
Covetrus's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Human Resources Officer | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | VP, Corporate Controller and Chief Accounting Officer | Reveal Email/Phone |
5 | CFO Europe | Reveal Email/Phone |
6 | CFO UK | Reveal Email/Phone |
7 | Chief Technology Officer | Reveal Email/Phone |
8 | EVP and Chief Financial Officer | Reveal Email/Phone |
9 | Executive Assistant to President North America | Reveal Email/Phone |
10 | Head Global Procurement & Travel | Reveal Email/Phone |
Covetrus Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8550M | 18080 | 8% | $451M | $18.8B |
#2 | $182.6M | 649 | 21% | $60M | N/A |
#3 | $12240M | 14592 | 2% | N/A | $10.8B |
#4 | $0.8M | 6 | N/A | N/A | N/A |
#5 | $7620M | 12220 | 6% | $40M | $97.5B |
What Is Covetrus?
Covetrus is a global market leader in animal-health technology and services, dedicated to advancing the world of veterinary medicine and empowering veterinary healthcare teams across the companion, equine, and large-animal health markets. We provide a comprehensive suite of products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals.
keywords:N/AN/A
Total Funding
3269
Number of Employees
$4.6B
Revenue (est)
3%
Employee Growth %
$2.2B
Valuation
N/A
Accelerator
Covetrus News
IDEXX Laboratories, Covetrus, Patterson Companies, Carestream Health, Timeless Veterinary Systems, Ezyvet, Via Information Systems,...
Covetrus, Inc. (NASDAQ:CVET Get Rating) has earned an average rating of Buy from the seven analysts that are presently covering the firm...
Get Covetrus alerts: This table compares Covetrus and General Cannabis' net margins, return on equity and return on assets.
Covetrus Announces Financial Results for Third Quarter of 2021 •Third quarter GAAP net sales of $1.16 billion, an increase of 3% year-over-year; non-GAAP organic net sales increased 3% year-over-year •Third quarter GAAP net loss attributable to Covetrus of $(4) million versus GAAP net loss att ...
ESG commitments help illustrate company's culture and benchmark future goals PORTLAND, Maine (August 5, 2021) - Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today released its first Environmental, Social and Governance report since forming just over two ye ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $828.1M | 3286 | N/A | N/A |
#2 | $1128.5M | 3290 | 9% | N/A |
#3 | $894.9M | 3551 | N/A | N/A |
#4 | $664.5M | 3651 | N/A | N/A |
#5 | $1145.5M | 3719 | 4% | $8.4B |